Lamprecht, D. A., Wall, R. J., Leemans, A., Truebody, B., Sprangers, J., Fiogbe, P., Davies, C., Wetzel, J., Daems, S., Pearson, W., Pillay, V., Saylock, S., Ricketts, M. D., Davis, E., Huff, A., Grell, T., Lin, S., Gerber, M., Vos, A., Dallow, J., Willcocks, S. J., Roubert, C., Sans, S., Desorme, A., Chappat, N., Ray, A., Moraes, M. P., Washington, T., D’Erasmo, H., Sancheti, P., Everaerts, M., Monshouwer, M., Esquivias, J., Larrouy-Maumus, G., Akli, R. D., Fletcher, H., Pym, A. S., Aldridge, B. B., Sarathy, J. P., Clancy, K. W., Stoops, B., Dhar, N., Steyn, A. J. C., Jackson, P., Aguilar-Pérez, C., Koul, A. (2025). Targeting de novo purine biosynthesis for tuberculosis treatment. Nature. https://doi.org/10.1038/s41586-025-09177-7